Search results
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
J&J's Janssen to close part of its vaccine division -Telegraaf
Reuters via Yahoo Finance· 8 months agoAMSTERDAM (Reuters) -Johnson & Johnson's Janssen division, which helped to develop its single-dose...
Illumina (ILMN) Extends Partnership to Advance Cancer Test
Zacks via Yahoo Finance· 4 months agoIllumina, Inc. ILMN recently entered into an agreement with Janssen Research & Development, LLC...
Q1 2023 Fate Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 months agoParticipants Bahram Valamehr; Chief Research & Development Officer; Fate Therapeutics, Inc. Edward J. Dulac; CFO; Fate Therapeutics, Inc. J. Scott Wolchko; Founder, CEO, President & Director ...
Protagonist (PTGX) Up on Positive Results From FRONTIER Study
Zacks via Yahoo Finance· 1 year agoShares of Protagonist Therapeutics, Inc. PTGX surged 51.91% on Mar 7 after the company announced...
LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection
Zacks via Yahoo Finance· 11 months agoLAVA Therapeutics’ LVTX shares were up almost 27% on Jun 1, after market hours. This followed soon...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
Theravance (TBPH) Q3 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 1 year agoTheravance Biopharma, Inc. TBPH reported third-quarter 2022 net loss of 21 cents per share, narrower...
Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 1 year agoTheravance Biopharma TBPH reported fourth-quarter 2022 net loss of 21 cents per share, narrower than...
Johnson & Johnson's Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder
Benzinga via Yahoo Finance· 1 year agoJanssen, a unit of Johnson & Johnson (NYSE: JNJ), announced topline results from the...